Document:

<PAGE>   1
                                                                    Exhibit 10.3

SCHEDULE A

THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE
STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE
OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SAID
ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO RNETHEALTH.COM, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.

                                Right to Purchase 1,015,000 Shares of Common
                                Stock of RNETHealth.com, Inc. (subject to
                                adjustment as provided herein)

                          COMMON STOCK PURCHASE WARRANT

No. 1                                                         September 13, 1999

        RNETHEALTH.COM, INC., a corporation organized under the laws of the
State of Colorado (the "Company"), hereby certifies that, for value received,
ROBERT PORTRIE, is entitled, subject to the terms set forth below, to purchase
from the Company, upon execution of the Invitation to join the Board of
Directors of the Company, at any time or from time to time before 5:00 p.m.,
Pacific Standard Time, on September 15, 2001 (the "Expiration Date"), up to
1,015,000 fully paid and nonassessable shares of Common Stock (as hereinafter
defined), $.01 par value per share, of the Company, at a purchase price of $.15
per share (such purchase price per share as adjusted from time to time as herein
provided is referred to herein as the "Purchase Price"). The number and
character of such shares of Common Stock and the Purchase Price are subject to
adjustment as provided herein.

        As used herein the following terms, unless the context otherwise
requires, have the following respective meanings:

        (a) The term Company shall include RNETHealth.com, Inc. and any
corporation which shall succeed or assume the obligations of RNETHealth.com,
Inc. hereunder.

        (b) The term "Common Stock" includes (a) the COmpany's Common Stock,
$.01 par value as authorized on the date of the Agreement, (b) any other capital
stock of any class or classes (however designated) of the Company, authorized on
or after such date, the holders of which shall have the right, without
limitation as to amount, either to all or to share of the balance of current

<PAGE>   2
dividends and liquidating dividends after the payment of dividends and
distributions on any shares entitled to preference, and the holders of which
shall ordinarily, in the absence of contingencies, be entitled to vote for the
election of a majority of directors of the Company (even if the right so to vote
has been suspended by the happening of such a contingency) and (c) any other
securities into which or for which any of the securities described in (a) or (b)
may be converted or exchanged pursuant to a plan of recapitalization,
reorganization, merger, sale of assets or otherwise.

        (c) The term "Other Securities" refers to any stock (other than Common
Stock) and other securities of the Company or any other person (corporate or
otherwise) which the holder of the Warrant at any time shall be entitled to
receive, or shall have received, on the exercise of the Warrant, in lieu of or
in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for or in replacement of Common Stock or Other
Securities pursuant to Section 5 or otherwise.

        1. Exercise of Warrant.

               1.1. Number of Shares Issuable upon Exercise. From and after the
date hereof through and including the Expiration Date, the holder hereof shall
be entitled to receive, upon exercise of this Warrant in whole in accordance
with the terms of subsection 1.2 or upon exercise of this Warrant in part in
accordance with subsection 1.3, the number of shares of Common Stock of the
Company identified on Page 1 hereof, subject to adjustment pursuant to Section
4.

               1.2. Full Exercise. This Warrant may be exercised in full by the
holder hereof by surrender of this Warrant, with the form of subscription
attached as Exhibit A hereto (the "Subscription Form") duly executed by such
holder, to the Company at its principal office or at the office of its Warrant
agent (as provided in Section 11), accompanied by payment, in cash or by
certified or official bank check payable to the order of the Company, in the
amount obtained by multiplying the number of shares of Common Stock for which
this Warrant is then exercisable by the Purchase Price (as hereinafter defined)
then in effect.

               1.3. Partial Exercise. This warrant may be exercised in part (but
not for a fractional share) by surrender of this Warrant in the manner and at
the place provided in subsection 1.2 except that the amount payable by the
holder on such partial exercise shall be the amount obtained by multiplying (a)
the number of shares of Common Stock designated by the holder in the
Subscription Form by (b) the Purchase Price then in effect. On any such partial
exercise, the

<PAGE>   3
Company, at its expense, will forthwith issue and deliver to or upon the order
of the holder hereof a new warrant of like tenor, in the name of the holder
hereof or as such holder (upon payment by such holder of any applicable transfer
taxes), may request, the number of shares of Common Stock for which such Warrant
may still be exercised.

               1.4. Fair Market Value. Fair Market Value of a share of Common
Stock as of a particular date (the "Determination Date") shall mean the Fair
Market Value of a share of the Company's Common Stock. Fair Market Value of a
share of Common Stock as of a Determination Date shall mean:

                      (a) If the Company's Common Stock is traded on an exchange
or is quoted on the National Association of Securities Dealers, Inc. Automated
Quotation ("NASDAQ") National Market System or the NASDAQ SmallCap Market, then
the closing or last sale price, respectively, reported for the last business day
immediately preceding the Determination Date.

                      (b) If the Company's Common Stock is not traded on an
exchange or on the NASDAQ National Market System or the NASDAQ SmallCap Market
but is traded in the over-the-counter market, then the mean of the closing bid
and asked prices reported for the last business day immediately preceding the
Determination Date.

                      (c) Except as provided in clause (d) below, if the
Company's Common Stock is not publicly traded, then as the Holder and the
Company agree or in the absence of agreement by arbitration in accordance with
the rules then standing of the American Arbitration Association, before a single
arbitrator to be chosen from a panel of persons qualified by education and
training to pass on the matter to be decided.

                      (d) If the Determination Date is the date of a
liquidation, dissolution or winding up, or any event deemed to be a liquidation,
dissolution or winding up pursuant to the Company's charter, then all amounts to
be payable per share to holders of the Common Stock pursuant to the charter in
the event of such liquidation, dissolution or winding up, plus all other amounts
to be payable per share in respect of the Common Stock in liquidation under the
charter, assuming for the purposes of this clause (d) that all of the shares of
Common Stock then issuable upon exercise of all of the Warrants are outstanding
at the Determination Date.

               1.5. Company Acknowledgment. The Company will, at the time of the
exercise of the Warrant, upon the request of the holder hereof acknowledge in
writing its continuing obligation to afford to such

<PAGE>   4
holder any rights to which such holder shall continue to be entitled after such
exercise in accordance with the provisions of this Warrant. If the holder shall
fail to make any such request, such failure shall not affect the continuing
obligation of the Company to afford to such holder any such rights.

               1.6. Trustee for Warrant Holders. In the event that a bank or
trust company shall have been appointed as trustee for the holders of the
Warrants pursuant to Subsection 3.1, such bank or trust company shall have all
the powers and duties of a warrant agent appointed pursuant to Section 10 and
shall accept, in its own name for the account of the Company or such successor
person as may be entitled thereto, all amounts otherwise payable to the Company
or such successor, as the case may be, on exercise of this Warrant pursuant to
this Section 1.

        2. Delivery of Stock Certificates, etc. on Exercise. The Company agrees
that the shares of Common Stock purchased upon exercise of this Warrant shall be
deemed to be issued to the holder hereof as the record owner of such shares as
of the close of business on the date on which this Warrant shall have been
surrendered and payment made for such shares as aforesaid. As soon as
practicable after the exercise of this Warrant in full or in part, and in any
event within 10 days thereafter, the Company at its expense (including the
payment by it of any applicable issue taxes) will cause to be issued in the name
of and delivered to the holder hereof, or as such holder (upon payment by such
holder of any applicable transfer taxes) may direct, a certificate or
certificates for the number of duly and validly issued, fully paid and
nonassessable shares of Common Stock (or other Securities) to which such holder
shall be entitled on such exercise, plus, in lieu of any fractional share to
which such holder would otherwise be entitled, cash equal to such fraction
multiplied by the then Fair Market Value of one full share, together with any
other stock or other securities and property (including cash, where applicable)
to which such holder is entitled upon such exercise pursuant to Section 1 or
otherwise.

        3. Adjustment for Reorganization, Consolidation, Merger, etc.

               3.1. Reorganization, Consolidation, Merger, etc. In case at any
time or from time to time, the Company shall (a) effect a reorganization, (b)
consolidate with or merge into any other person, or (c) transfer all or
substantially all of its properties or assets to any other person under any plan
or arrangement contemplating the dissolution of the Company, then, in each such
case, as a condition to the consummation of such a transaction, proper and
adequate provision shall be made by the Company whereby the holder of this
Warrant, on

<PAGE>   5

the exercise hereof as provided in Section 1 at any time after the consummation
of such reorganization, consolidation or merger or the effective date of such
dissolution, as the case may be, shall receive, in lieu of the Common Stock (or
Other Securities) issuable on such exercise prior to such consummation or such
effective date, the stock and other securities and property (including cash) to
which such holder would have been entitled upon such consummation or in
connection with such dissolution, as the case may be, if such holder had so
exercised this Warrant, immediately prior thereto, all subject to further
adjustment thereafter as provided in Section 5.

               3.2. Dissolution. In the event of any dissolution of the Company
following the transfer of all or substantially all of its properties or assets,
the Company, prior to such dissolution, shall at its expense deliver or cause to
be delivered the stock and other securities and property (including cash, where
applicable) receivable by the holders of the Warrants, if exercised, after the
effective date of such dissolution pursuant to this Section 3 to a bank or trust
company having its principal office in New York, NY, as trustee for the holder
or holders of the Warrants.

               3.3. Continuation of Terms. Upon any reorganization,
consolidation, merger or transfer (and any dissolution following any transfer)
referred to in this Section 3, this Warrant shall continue in full force and
effect and the terms hereof shall be applicable to the shares of stock and other
securities and property receivable on the exercise of this Warrant after the
consummation of such reorganization, consolidation or merger or the effective
date of dissolution following any such transfer, as the case may be, and shall
be binding upon the issuer of any such stock or other securities, including, in
the case of any such transfer, the person acquiring all or substantially all of
the properties or assets of the Company, whether or not such person shall have
expressly assumed the terms of this Warrant as provided in Section 5.

        4. Extraordinary Events Regarding Common Stock. In the event that the
Company shall (a) issue additional shares of the Common Stock as a dividend or
other distribution on outstanding Common Stock, (b) subdivide its outstanding
shares of Common Stock, or (c) combine its outstanding shares of the Common
Stock into a smaller number of shares of the Common Stock, then, in each such
event, the Purchase Price shall, simultaneously with the happening of such
event, be adjusted by multiplying the then Purchase Price by a fraction, the
numerator of which shall be the number of shares of Common Stock outstanding
immediately prior to such event and the denominator of which shall be the number
of shares of Common Stock outstanding immediately after such event, and the
product so obtained shall thereafter be the

<PAGE>   6
Purchase Price then in effect. The Purchase Price, as so adjusted, shall be
readjusted in the same manner upon the happening of any successive event or
events described herein in this Section 4. The number of shares of Common Stock
that the holder of this Warrant shall thereafter, on the exercise hereof as
provided in Section 1, be entitled to receive shall be increased to a number
determined by multiplying the number of shares of Common Stock that would
otherwise (but for the provisions of this Section 4) be issuable on such
exercise by a fraction of which (a) the numerator is the Purchase Price that
would otherwise (but for the provisions of this Section 4) be in effect, and (b)
the denominator is the Purchase Price in effect on the date of such exercise.

        5. Chief Financial Officer's Certificate as to Adjustments. In each case
of any adjustment or readjustment in the shares of Common Stock (or Other
Securities) issuable on the exercise of the Warrants, the Company at its expense
will promptly cause its Chief Financial Officer to compute such adjustment or
readjustment in accordance with the terms of the Warrant and prepare a
certificate setting forth such adjustment or readjustment and showing in detail
the facts upon which such adjustment or readjustment is based, including a
statement of (a) the consideration received or receivable by the Company for any
additional shares of Common Stock (or Other Securities) issued or sold or deemed
to have been issued or sold, (b) the number of shares of Common Stock (or Other
Securities) outstanding or deemed to be outstanding, and (c) the Purchase Price
and the number of shares of Common Stock to be received upon exercise of this
Warrant, in effect immediately prior to such adjustment or readjustment and as
adjusted or readjusted as provided in this Warrant. The Company will forthwith
mail a copy of each such certificate to the holder of the Warrant and any
Warrant agent of the Company (appointed pursuant to Section 10 hereof).

        6. Reservation of Stock, etc., Issuable on Exercise of Warrant;
Financial Statements. The Company will at all times reserve and keep available,
solely for issuance and delivery on the exercise of the Warrants, all shares of
Common Stock (or Other Securities) from time to time issuable on the exercise of
the Warrant. This Warrant entitles the holder hereof to receive copies of all
financial and other information distributed or required to be distributed to the
holders of the Company's Common Stock.

        7. Assignment; Exchange of Warrant. Subject to compliance with
applicable Securities laws, and delivery of such representations and warranties
as shall reasonably be requested by the Company, this warrant, and the rights
evidenced hereby, may be transferred by any registered holder hereof (a
"Transferor") with respect to any or all

<PAGE>   7
of the Shares. on the surrender for exchange of this Warrant, with the
Transferor's endorsement in the form of Exhibit B attached hereto (the
"Transferor Endorsement Form"), to the Company, the Company at its expense but
with payment by the Transferor of any applicable transfer taxes) will issue and
deliver to or on the order of the Transferor thereof a new Warrant or Warrants
of like tenor, in the name of the Transferor and/or the transferee(s) specified
in such Transferor Endorsement Form (each a "Transferee"), calling in the
aggregate on the face or faces thereof for the number of shares of Common Stock
called for on the face or faces of the Warrant so surrendered by the Transferor.

        8. Replacement of Warrant. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of
this warrant and, in the case of any such loss, theft or destruction of this
Warrant, on delivery of an indemnity agreement or security reasonably
satisfactory in form and amount to the Company or, in the case of any such
mutilation, on surrender and cancellation of this Warrant, the Company at its
expense will execute and deliver, in lieu thereof, a new Warrant of like tenor.

        9. Warrant Agent. The Company may, by written notice to the each holder
of the Warrant, appoint an agent having an office in New York, NY for the
purpose of issuing Common Stock (or Other Securities) on the exercise of this
Warrant pursuant to Section 1, exchanging this Warrant pursuant to Section 7,
and replacing this Warrant pursuant to Section 8, or any of the foregoing, and
thereafter any such issuance, exchange or replacement, as the case may be, shall
be made at such office by such agent.

        10. Transfer on the Company's Books. Until this Warrant is transferred
on the books of the Company, the Company may treat the registered holder hereof
as the absolute owner hereof for all purposes, notwithstanding any notice to the
contrary.

        11. Notices, etc. All notices and other communications from the Company
to the holder of this Warrant shall be mailed by first class registered or
certified mail, postage prepaid, at such address as may have been furnished to
the Company in writing by such holder or, until any such holder furnishes to the
Company an address, then to, and at the address of, the last holder of this
Warrant who has so furnished an address to the Company.

        12. Miscellaneous. This Warrant and any term hereof may be changed,
waived, discharged or terminated only by an instrument in writing signed by the
party against which enforcement of such change, waiver, discharge or termination
is sought. This Warrant shall be

<PAGE>   8

construed and enforced in accordance with and governed by the laws of New York.
Any dispute relating to this Warrant shall be adjudicated in New York State. The
headings in this Warrant are for purposes of reference only, and shall not limit
or otherwise affect any of the terms hereof. The invalidity or unenforceability
of any provision hereof shall in no way affect the validity or enforceability of
any other provision.

        IN WITNESS WHEREOF, the Company has executed this Warrant under seal as
of the date first written above.

                                      RNETHEALTH.COM, INC.

                                      By:
                                         -----------------------------------

                                      Title:
                                            --------------------------------

Witness:

----------------------------
<PAGE>   9

                                    Exhibit A

                              FORM OF SUBSCRIPTION
                   (To be signed only on exercise of Warrant)

TO: RNETHealth.com, Inc.

The undersigned, the holder of the within Warrant, hereby irrevocably elects to
exercise this Warrant for, and to purchase thereunder, ______shares of Common
Stock of RNETHealth.com, Inc. and herewith makes payment of $_______ therefor,
and requests that the certificates for such shares be issued in the name of, and
delivered to_______ whose address is_____________.

Dated:
      ------------------

                                ---------------------------------------------
                                (Signature must conform to name of holder as
                                specified on the face of the Warrant)

                                ---------------------------------------------
                                (Address)
<PAGE>   10

                                                                       Exhibit B

                         FORM OF TRANSFEROR ENDORSEMENT
                   (To be signed only on transfer of Warrant)

               For value received, the undersigned hereby sells, assigns, and
transfers unto the person(s) named below under the heading "Transferees" the
right represented by the within Warrant to purchase the percentage and number of
shares of Common Stock of RNETHealth.com, Inc. to which the within Warrant
relates specified under the headings "Percentage Transferred" and "Number
Transferred," respectively, opposite the name(s) of such person(s) and appoints
each such person Attorney to transfer its respective right on the books of
RNETHealth.com, Inc. with full power of substitution in the premises.

================================================================================
Transferees                   Percentage                     Number
                             Transferred                 Transferred
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

================================================================================

Dated:_______________, 19__

                                ------------------------------------------------
                                (Signature must conform to name of holder as
                                specified on the face of the warrant)

Signed in the presence of:

----------------------------    ------------------------------------------------
         (Name)                                   (address)

                                ------------------------------------------------
ACCEPTED AND AGREED:                              (address)
[TRANSFEREE]

----------------------------
        (Name)

                                      -19-<PAGE>   1
                                                                   Exhibit 10.41

                                WARRANT AMENDMENT

         This SECOND WARRANT AMENDMENT AGREEMENT ("Agreement"), dated as of the
date set forth below, by and between LITHIUM TECHNOLOGY CORPORATION, a Delaware
corporation ("LTC") and the holder (the "Warrant Holder") of the warrant (the
"Warrant") set forth below.

                                    RECITALS

         WHEREAS, LTC and the Warrant Holder have entered into a Warrant
Agreement relating to the warrants set forth below under the Warrant Holder's
name (the "Warrants").

         WHEREAS, LTC and the Warrant Holder have entered into a Warrant
Amendment Agreement pursuant to which the exercise price of the Warrants was
reduced to $.15 and the vesting of the Warrant was accelerated in exchange for
the consent of the holder of the Warrant to a new termination date for the
Warrant of the earlier of the original termination date of the Warrant and the
date 30 days prior to the closing of the merger between the Company and Ilion
Technology Corporation ("Ilion"), formerly known as Pacific Lithium Limited,
(the "Merger").

         WHEREAS, the Company has been unable to file a registration statement
with the United States Securities and Exchange Commission (the "SEC") in order
to allow the holder of the Company's warrants to have the ability to freely sell
the underlying warrant shares (the "Selling Stockholder Registration
Statement").

         WHEREAS, the Board of Directors of the Company has approved the
extension of the termination date of all outstanding Company warrants as set
forth below in order to give the Warrant Holders the ability to include the
Warrant Shares in any Selling Stockholder Registration Statement filed with the
SEC prior to the closing of the Merger.

         NOW, THEREFORE, in consideration of these premises and the mutual
agreements contained in this Agreement, the Warrant Holder and LTC agree as
follows:

1.       The following provision of the Warrant is amended and restated as
         follows:

                  The Expiration Date of the Warrant is the earlier of (i) the
                  date three business days prior to the closing of the Merger or
                  (ii) the original expiration date set forth in the Warrant,
                  provided however, if there is no registration statement
                  registering the underlying warrant shares effective within
                  thirty days prior to the original Warrant Expiration Date, the
                  original Warrant Expiration Date is extended to the date three
                  business days prior to the closing of the Merger between
                  Lithium Technology Corporation and Ilion Technology
                  Corporation.

2.       This Agreement and any controversy which might arise herefrom will in
         all respects be interpreted, enforced and governed by the laws of the
         State of Delaware.

3.       This Agreement will be binding upon and inure to the benefit of the
         parties hereto and their respective heirs, representatives, successors
         and assigns.

4.       In consideration of the extension of the Expiration Date of the Warrant
         the Warrant Holder hereby releases LTC and its directors, officers,
         employees, attorneys, agents and affiliates from any and all claims
         relating to the Warrant. In all other respects, the Warrant is affirmed
         in its entirety.

5.       Each party hereto represents and warrants that it has carefully read
         this Agreement and knows the contents hereof and that it has signed
         this Agreement freely and voluntarily and that each party has obtained
<PAGE>   2
         independent counsel in reviewing this document and further acknowledges
         that the law firm of Gallagher, Briody & Butler has memorialized the
         within Agreement and has provided legal advice solely to LTC with
         respect to this Agreement.

6.       The Warrant Holder was provided the opportunity to retain individual
         counsel, and has retained or waived the right to retain individual
         counsel to review this Agreement.

7.       This Agreement may be amended only by a written agreement executed by
         or on behalf of each of the parties hereto.

8.       Each party hereto represents and declares that each of the persons
         executing this Agreement on its behalf is and will be duly empowered
         and authorized to do so.

Dated:  _______________, 2001      LITHIUM TECHNOLOGY CORPORATION

                                      By: ___________________________________
                                      David J. Cade
                                      Chairman and Chief Executive Officer

                                            WARRANT HOLDER

                                   Signature: _______________________________

                                   Print name:_______________________________

                                   Mailing Address:__________________________

                                   __________________________________________

                                   __________________________________________

                                   Number of Warrants Held:__________________
                                   Number of Warrant shares to be included
                                   in the registration statement:____________

                                   Date:_____________________________________

                                       19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}]]